Topline¹ revenue of $22.32 million, up 31% from 2023Record 2024 GAAP revenue of $16.04 million, up 39% from 20232024 Adjusted EBITDA¹ of +490K compared to ($1.38) million in ...

Gen Alpha (children 14 and younger) led the rise of GLP-1 utilization from 2023 to 2024, with an 85% growth rate in that period. But what is behind the sharp increase? 3 factors at play There are ...

Retail investors may be able to invest in private market investment funds. Here are some pointers on what to look out for in private equity ...

Weight loss drugs are a revolution for people who are seriously obese, but shouldn't we take a look at the ultra-processed foods causing our health problems first?

After falling significantly in recent months, Denny's has bounced back in tandem with the recent broad market relief rally.

Hims & Hers on Tuesday announced a collaboration with drugmaker Novo Nordisk to bundle Wegovy and a Hims & Hers membership on ...

Hims & Hers partners with Novo Nordisk to offer Wegovy access online with clinical support, expanding its weight loss care and revenue strategy.

As of last week, Chris Klomp is in charge of the Center for Medicare. Unlike predecessors, he’s not a policy wonk. Klomp was ...

Oprah Winfrey debuted a fresh look as she attended she opening night of Beyoncé's Cowboy Carter Tour in Los Angeles on Monday.

Service GLP-1 Medication Platform Offering Affordable Access to Semaglutide, Tirzepatide, and Phentermine with 24/7 Coaching, ...

GLP-1 receptor agonists such as semaglutide and tirzepatide have proven to be highly effective in supporting weight loss by regulating appetite and metabolism. These medications work by mimicking ...

The global Oral Proteins & Peptides Market , valued at US$7.35 billion in 2024, is forecasted to grow at a robust CAGR of ...